Background: Graft-versus-host disease (GVHD) is initiated when alloreactive donor T cells are primed by host APCs to undergo clonal expansion and maturation. Since there is a controversy regarding the role of nonhematopoietic cells in GVHD, we wanted to investigate the influence of MHC disparity on nonhematopoietic cells on the pathogenesis of GVHD in the MHC-haplomismatched C57BL/6 (H- ) murine model of acute GVHD (aGVHD) or chronic GVHD (cGVHD). Methods: We generated (BDF1→C57BL/6), (BDF1→DBA/2), and (BDF1→BDF1) chimeras and examined GVHD-related parameters and donor cell engraftment in those chimeras. Results: Using this experimental system, we found that 1) severe aGVHD across MHC Ag barrier depends on the expression of nonhematopoietically rather than hematopoietically derived alloAgs for maximal GVHD manifestations; 2) host APCs were sufficient to break B cell tolerance to self molecules in cGVHD, whereas host APCs were insufficient to induce autoimmunity in aGVHD; 3) donor cell engraftment was greatly enhanced in the host with MHC-matched nonhematopoietic cells. Conclusion: Taken together, our results provide an insight into how MHC disparity on GVHD target organs contribute to the pathogenesis of GVHD. 
INTRODUCTION
In the parent-into-F 1 graft-versus host disease (GVHD) model, the genetic background of donor strains is critical in determining the outcome of GVHD (1, 2) . For example, the infusion of donor T cells from the DBA/2 strain into an unirradiated (C57BL/6×DBA/2)F1 (BDF1) mouse induces chronic GVHD (cGVHD), whereas the infusion of T cells of the other parent, C57BL/6 (B6), induces acute GVHD (aGVHD) (3 (5, 6) , whereas donor CD8 ＋ T cells are differentiated into effector T cells that have the ability to delete host B cells including potential autoreactive B cells in aGVHD, thus depriving the host of the opportunity to produce autoAb (7) (8) (9) . It is controversial whether cognate interactions between TCRs and MHC on nonhematopoietic target tissues are required for GVHD (10) (11) (12) (13) . In MHC-mismatched GVHD, TCRs can directly recognize recipient MHC (10-12). Teshima et al. (13) have shown that CD4-mediated GVHD, and to a lesser extent CD8-mediated GVHD do not require such direct interactions, suggesting that the direct allorecognition of donor T cells on host APCs is critical in GVHD. It is not known how donor B6 T cells induce GVHD in the B6→BDF1 aGVHD model. In this study, F 1 →parent chimeras were used to elucidate the involvement of alloAg expression by nonhematopoietic tissues in the B6→BDF1 aGVHD model. Our results indicate that aGVHD induced solely by alloreactive donor T cells depends on the expression of nonhematopoietically rather than hematopoietically derived alloAgs. ) mice, 7∼8 wk of age, were purchased from Orient (Seoul, Korea). All mice were maintained in pathogen-free conditions. These studies were approved by institutional animal care committee.
MATERIALS AND METHODS

Mice
Abs and reagents
The following FITC-, PE-, PerCP-or biotin-conjugated mAbs to mouse proteins were purchased from BD Biosciences (San Diego, CA): CD4, CD8, B220, H-2K Remaining CD3 ＋ cells routinely comprised less than 1% of BM cells. Recipient BDF1 mice received 12 gray (Gy) irradiation from a cesium irradiator and were reconstituted with 5×10 6 T-cell-depleted BM from BDF1 mice.
Induction of GVHD GVHD was induced as described previously (14) (15) (16) . In brief, single-cell suspensions in PBS were prepared from spleens and lymph nodes of normal B6 or DBA2 donors, filtered through a sterile mesh (BD Biosciences), and washed. After the erythrocytes were lysed in hemolysis buffer, the remaining cells were resuspended at 8×10 7 cells/0.2 ml in PBS.
GVHD was induced by transfer of 8×10 7 of spleens/lymph node cells into the tail vein of unirradiated BDF 1 recipient mice at 12 wk after BM transplantation.
ELISA
Mice were bled from the tail vein, and serum titers of anti-DNA IgG1 were assessed by ELISA. Plates (96-well) were incubated overnight at 4 o C with 100 μl salmon sperm DNA (Sigma-Aldrich, St. Lois, MO) at a concentration of 10 μg/ml. After blocking with 2% BSA, the plates were incubated with 100 μl serially diluted serum samples for 1 h at room temperature. They were washed three times with PBS containing 0.1% Tween 20, and HRP-conjugated anti-mouse IgG1 was added to each well and the plates were kept at room temperature for 1 h. They were washed again with the same solution and color was developed in 100 μl 3,5,3',5'-tetramethylbenzene substrate (Pierce, Rockford, IL) for 10∼15 min and stopped by adding 100 μl of 1 N HCl. The plates were then read at 450 nm with a Wallac Vector 1420 Multilabel Counter (PerkinElmer, Waltham, MA). OD values at a 1/10 dilution of sera were presented.
Flow cytometry
The spleens of GVHD mice were harvested on the indicated days after parental cell transfer. After lysis of the erythrocytes, the splenocytes were preincubated in a blocking buffer (PBS containing 2.4G2 mAb/0.2% BSA/0.1% sodium azide), and then incubated with the relevant mAbs for 30 min at 4 o C. Finally, they were washed twice with staining buffer (PBS containing 0.2% BSA/0.1% sodium azide) and analyzed by FACscan (BD Biosciences).
Histopathology
Formalin-fixed kidney, liver, and large intestine were embedded in paraffin, and 5 μm thick sections were stained with H&E and evaluated by light microscopy. Slides for liver and large intestine were coded and further examined in a blinded fashion by one individual (H.J.C.), using a semiquantitative system for abnormalities known to be associated with aGVHD (17, 18) . In brief, samples of liver tissue was performed by scoring 14 pathologic features, including inflammatory infiltrates in bile ducts and portal tracts, vascular endothelialitis, and hepatocellular damage as previously reported. A severity scale from one to four was used where 0=normal, 0.5=rare scattered, 1=minimal or focal, 2=mild and more diffuse, 3=moderate damage, and 4=severe damage. Scores for each individual feature were added to yield a composite score of liver pathology. Colon abnormalities were assessed by examining crypt regeneration, surface coloncytes, colonocyte vacuolization, surface colonocyte attenuation, crypt cell apoptosis, outright crypt destruction, and lamina propria lymphocytic infiltrate. The scoring system denoted 0 as normal, 0.5 as focal and rare, 1.0 as focal and mild, 2.0 as diffuse and mild, 3.0 as diffuse and moderate, and 4.0 as diffuse and severe. Scores were added to provide a total score for each specimen. Only after scoring was performed were codes broken and data compiled.
Statistical analysis
The Student's t test was used to determine the statistical significance of differences between experimental groups. Error bars represent SD of the mean. Log-rank Mantel-Cox test was used for survival curves.
RESULTS
The parent-into-unirradiated GVHD model is unique among GVHD models in that the development of GVHD is initiated only by alloreactivity without inflammation induced by preconditioning. This property provides a less complication in interpreting experimental data and finds its usefulness in an experimental tool to dissect a variety of issues related to immune tolerance to alloAgs. In this study, we wanted to investigate the roles of nonhematopoietic cells in GVHD in the MHC-haplomismatched B6 or DBA/2→unirradiated BDF1 murine model of aGVHD or cGVHD. We created (BDF1→ B6), (BDF 1 →DBA/2), or (BDF 1 →BDF 1 ) chimeras. In this experiment system, allogeneic host APCs could stimulate donor T cells, regardless of MHC mismatch in nonhematopoietic cells. PBMCs were ＞90% donor-derived in BDF 1 →B6 or DBA/2 mice by 8 wk after BM transfer (Fig. 1) . We induced aGVHD in three sets of chimeras by transferring B6 spleen/lymph node cells. BDF 1 →DBA/2 chimeras had most severe aGVHD as measured by loss of body weight and histologic analysis of aGVHD target organs (Fig. 2) . Except for earlier death in a small portion of mice, BDF 1 →B6 chimeras barely showed clinical and pathologic symptoms of aGVHD. The earlier death could be due to a large quantity of cytokines produced when B6 donor T cells killed host BDF1 hematopoietic cells (also see Fig. 2; Ref 13 ). BDF 1 →BDF 1 control mice had milder aGVHD than BDF1→DBA/2 chimeras but more severe hepatic GVHD than BDF1→B6 chimeras. Taken together, our results indicate that severe aGVHD mediated by donor T cells depends on the expression of alloAgs in nonhematopoietic cells. A similar conclusion has been reached in CD8 ＋ T cellor CD4 ＋ T cell-mediated aGVGD across minor histocompatibility Ag (miHA) barrier (19, 20) . In our experimental system, TCRs of donor B6 T cells could recognize intact BDF1 MHC on host hematopoietic cells. Alloreactive donor T cells generated from these interactions could remove host hematopoietic cells and make a niche for donor hematopoietic stem cells. As shown in Fig.  3 , MHC disparity on nonhematopoietic cells had a reverse correlation with donor cell engraftment. Even though aGVHD was not evident in BDF 1 →B6 chimeras, more than 90% of splenocytes were of donor origin. In contrast, despite of severe aGVHD, DBF1→DBA/2 chimeras had the least extent of donor cell engraftment among the three sets of chimeras. Our data indicate that MHC disparity on nonhematopoietic cells is a greater hurdle to donor cell engraftment.
It is thought that alloreactive donor T cells exhibit an activation status in MHC-mismatched GVHD, because they receive sustained allostimulation. Consistent with this hypothesis, a greater number of activated CD4 ＋ T cells and CD8 ＋ T cells (CD62L low ) were contained in the spleen of BDF1→ DBA/2 chimeras and positive controls (BDF1→BDF1 mice), compared with BDF 1 →B6 mice (Fig. 4) . Therefore, our result suggests that alloreactive T cells in BDF 1 →B6 chimeras may remain quiescent after allogenic host hemtopoietic cells are removed. The DBA/2→BDF 1 cGVHD model has been extensively utilized to study how alloimmunity breaks B-cell tolerance to self molecules (21) . Using this model, we wanted to examine the effect of MHC disparity on nonhematopoietic cells on autoimmunity and donor cell engraftment. cGVHD was induced by transferring DBA/2 spleen/lymph node cells into BDF1→ B6, BDF 1 →DBA/2, and BDF 1 →BDF 1 chimeras. As shown in Fig. 5A , DBA/2 donor T cells were equally potent in inducing production of IgG1 anti-DNA autoAb in all of the three sets of chimeras, suggesting that MHC disparity on hematopoietic cells are sufficient for but MHC disparity on nonhematopoietic cells are not involved in the development of cGVHD. Furthermore, it seems that mortality due to cGVHD was not influenced by MHC disparity on nonhematoietic cells: there was no difference in the rate of mortality between BDF 1 → DBA/2 and BDF1→B6 chimeras (Fig. 5B) . Histopathological analysis showed that the kidney of either BDF1→DBA/2 or BDF 1 →B6 chimeras had severe glomerulonephritis (Fig. 5C) . Nontherless, engraftment of donor lymphocytes, including CD4 ＋ T cells, CD8 ＋ T cells, and B cells, was significantly higher in BDF 1 →DBA/2 than in BDF 1 →B6 chimeras, although the two groups had no difference in the percent of total donor cell engraftment (Fig. 6) . Levels of donor lymphocyte engraftment were positively correlated with the extent of donor CD8 ＋ T cell activation (Fig. 7) . These results sug-IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 2 April 2010 gest that MHC match on nonhematopoietic cells is critical in donor cell engraftment, as shown in the B6→BDF1 aGVHD model.
DISCUSSION
In the B6→BDF1 aGVHD model, theoretically, MHC-haplomismatched host APCs can not only stimulate donor T cells through interactions between allo-MHC and TCRs but also present processed alloAgs or self-Ags to donor T cells in the context of self-MHC. Our results suggest that, even though GVHD is initiated by donor T cells after receiving allostimulation by host APCs, through the direct alloreactive pathway (22) , presentation of nonhematopoietically derived alloAgs by donor APCs is a prerequisite for the propagation of the disease. It seems that (BDF 1 →B6) chimeras experience transient cachexia (which sometimes results in mortality) with reduced target-tissue injury over time, reflecting an early, limited graft-versus-host response. This interpretation is consistent with results obtained from various MHC-matched ormismatched aGVHD models (23) (24) (25) (26) (27) .
It is still controversial whether the expression of nonhematopoietically derived alloAgs is required for CD4-mediated aGVHD. Two sharp contrast results have been reported (13, 20) . Teshima et al. (13) pression by the hematopoietic compartment alone was sufficient to obtain lethal GVHD, whereas Jones et al. (20) demonstrated significantly diminished B6 CD4 ＋ T cell-mediated GVHD development when recipient BALB.B mHAs were exclusively derived from cells of the hematopoietic compartment. This discrepancy may be due to differences in the allogeneic T cell response directed across MHC versus mHA barriers, most notably the involvement of a much higher alloreactive CD4 ＋ T cell precursor frequency in the former situation (28) .
In bm12→B6 (20) and similar models (18, (29) (30) (31) (32) , such a vigorous T cell response can rapidly generate high levels of proinflammatory cytokines responsible for initiating acute tissue damage in the early post-hematopoietic stem cell transplantation period. However, our results suggest that alloreactive T cells generated by the exposure to allogeneic host APCs are insufficient to drive fully developed GVHD in the absence of preconditioning. Therefore, proinflammatory cytokines produced as a result of preconditioning such as total body irradiation play a critical role in the induction of GVHD, presumably in synergy with a donor T cell response or/and by helping the broadening of the pool of alloreactive donor T cells (33) (34) (35) . In either case, the data suggest that alloreactive donor T cells generated from either the direct pathway (by allogeneic host APCs) or the indirect pathway (nonhematopoietically derived alloAgs are presented by host or donor APCs) mediate GVHD with great help of proinflammatory cytokines triggered by preconditioning. It is well known that GVHD, in particular, cGVHD, has clinical manifestations of autoimmune disorders (36) (37) (38) . Our observations showing that BDF1→B6 chimeras did not display aGVHD after transfer of B6 T cells suggest that allogeneic host APCs is insufficient to break self-tolerance. Since GVHD-induced autoreactivity is donor APC-dependent in irradiated recipient mice (39) , and BDF1 APCs can present self-Ags to donor B6 T cells in BDF1→B6 chimeras, proinflammatory cytokines produced as a result of preconditioning may facilitate autoimmunity by donor T cells. In such irradiated models, autoimmunity is evolved as aGVHD is progressing (24) . In our cGVHD model, alloreactive donor T cells (CD4 ＋ T cells) rapidly broke B cell tolerance regardless of MHC match on nonhematopoietic cells. Therefore, a certain genetic combination of MHC disparity between donors and recipients may be a risk factor for SLE-like cGVHD, especially in patients with transient or chronic states of mixed chimerism. However, clinical correlates of these observations should be established.
In the B6→BDF 1 aGVHD model, alloreactive donor CD8 ＋ T cells kill host hematopoietic cells for donor cell engraftment. Surprisingly, donor cell engraftment is not positively correlated with the severity of GVHD. This observation suggests that donor-recipient genetic combinations may exist where donor T cells do not induce GVHD with intact donor cell engraftment and thus intact graft-versus-leukemia effects. It will be important to search for a genetic factor that governs donor cell engraftment.
